在3个潜在的美国队列中使用多种维生素和死亡风险
Erikka Loftfield1, Caitlin P O'Connell1, Christian C Abnet1
1Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
JAMA network open
|June 26, 2024
概括
美国成年人使用多种维生素 (MV) 与死亡风险降低无关. 这项大型队列研究发现,每日多维生素补充剂对死亡率没有显著的益处.
科学领域:
- 营养流行病学 营养流行病学
- 公共卫生 公共卫生
- 预防医学 预防医学
背景情况:
- 美国成年人广泛使用多种维生素 (MV),通常用于疾病预防.
- 之前的审查发现,由于研究的局限性,对MV补充剂对死亡率的影响的证据不足.
研究的目的:
- 调查复合维生素使用与死亡风险之间的关联.
- 为了考虑潜在的混因素,如健康的生活方式和反向因果关系.
主要方法:
- 分析了来自美国三项大型前性队列研究 (NIH-AARP,PSC,AHS) 的数据.
- 包括39万多名没有先前慢性疾病的成年人.
- 随访时间延长至27年,并进行详细的混杂因素评估.
主要成果:
- 多种维生素的使用没有与降低全因死亡风险的相关性.
- 死亡风险比率在早期和晚期随访期间都相似.
- 在主要死亡原因中没有观察到任何显著的死亡益处.
结论:
- 这项大型队列研究表明,多种维生素的使用与美国成年人的死亡率益处无关.
- 研究结果表明,广泛使用多种维生素维持健康可能与可证明的生存优势不一致.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Bioavailability: Overview
2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K
Comparing the Survival Analysis of Two or More Groups
176
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
176
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K


